Cure8 research brief
This study proposes three autophagy-related genes (APOL1, CCL2, IL24) as potential biomarkers that may help classify ulcerative colitis patients into subtypes with different immune environments, which could eventually inform research toward more targeted therapies or diagnostics.
Researchers studying IBD pathogenesis, biomarkers, and single-cell genomics; clinicians interested in molecular stratification research; translational scientists developing diagnostic biomarkers.
This preprint-style Research Square posting reports an analysis of public gene-expression datasets and single-cell RNA sequencing to identify autophagy-related differentially expressed genes in ulcerative colitis (UC).
The authors highlight three genes (APOL1, CCL2, IL24) that they used to build a diagnostic risk model and to define two molecular subtypes with different immune-infiltration patterns. Single-cell analysis and qRT-PCR in mouse and human tissue are reported to support cell-type–specific expression in endothelial cells and fibroblasts.
The findings are presented as potential biomarkers and as a way to subgroup UC by autophagy-related signatures, but the work is discovery-oriented rather than a clinical test; the diagnostic model is based on retrospective datasets and experiments described in the paper rather than a prospective clinical validation.
If you are following biomarker or molecular-subtyping research in IBD, this paper contributes candidate genes and single-cell observations that could be followed up in larger, clinically annotated cohorts and functional studies.
Structured content depth: abstract — the Cure8 brief is grounded in the article abstract and extracted text from the Research Square posting. This is a discovery/bench research report posted on Research Square (preprint-style); findings have not been established as clinically validated diagnostics or therapies and require independent replication and prospective validation.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study links shared gene-expression patterns between IBD and ankylosing spondylitis and highlights STAT3 as a potential shared biomarker or therapeutic target, which could be relevant for understanding overlapping...
The paper suggests a molecular link (RHBDF2–ADAM17–TNFα) between ulcerative colitis and blood–brain barrier disruption, which could explain some neurological comorbidities of UC and identify targets for future therapies.
The work highlights macrophage metabolic programs and specific genes that may help classify UC molecular subtypes and suggest candidate biomarkers or therapeutic targets related to macrophage-driven inflammation.
